top of page
  • Writer: Clear Solutions team
    Clear Solutions team
  • Feb 5
  • 5 min read

Clear Solutions reduces child mortality from diarrhoea by improving access to, and usage of, highly effective treatments, ORS and zinc (ORSZ). We have increased focus on ‘layering’ free ORSZ provision onto existing health infrastructure (as opposed to dedicated door-to-door distributions, see layering blog post), and see local medicine vendors as key potential partners. In northern Nigeria, patent and proprietary medicine vendors (PPMVs, or ‘kemis’) are present in a large proportion of communities, even in more rural areas, and are often a caregiver’s first point of call if seeking help for a sick child.  


Aiming both to reach a large proportion of caregivers in communities, and to improve upon the costs involved in regular dedicated door-to-door campaigns (as may be required to sustain treatment coverage over time), we decided to pilot a voucher system with PPMVs. The model uses vouchers issued to each primary caregiver of children under-5 within a community, with the vouchers reusable for periodic claiming of free ORSZ (and/or other commodities) over a period of a year+. Each voucher has a QR code that is scanned by the vendor to record redemption of the voucher and prevent repeat claims within a defined time period.


We are building this distribution model guided by evidence from voucher program RCTs, including for chlorine water treatments in Dupas et al, 2017; & Dupas et al, 2023, which showed strong results in Kenya and Malawi respectively. Indeed, we see potential for our voucher implementation to work well for point of use chlorine water treatments such as Water Guard Plus, which may be a strong complement to ORSZ. But first, we are focused on refining and evaluating the model for ORSZ.


Pilot structure


For the purposes of a short-term pilot, we issued 2 identical single-use vouchers per caregiver instead of the more physically robust reusable format mentioned above. This was to manage caregiver expectations around the duration of the pilot (2 vouchers = 2 months), in anticipation that learnings from the pilot would lead to changes in the vouchers themselves in future iterations. It also meant that we could test the scanning technology handling of periodic scans of the same voucher code (like a single re-usable voucher) , while also - for the pilot only - having the PPMVs collect the paper vouchers as a backup to the digital tracking system.


The pilot was implemented by 4 PPMVs serving communities in Kabo local government area (LGA), Kano state, Nigeria, from November 2025 to January 2026. We worked in partnership with iDevPro Africa, Kano State Ministry of Health, and the PPMV trade association NAPPMED.


To evaluate the impact of the intervention, a survey team performed household surveys of caregivers before and after the vouchers implementation period. The primary outcome measure is the proportion of under-5s’ diarrhoea cases treated with ORS and zinc, with contextual information and feedback on the pilot implementation also collected.


Distributing & registering the vouchers


In each of the communities served by the pilot PPMVs, 1-2 local women (“Frontline Workers”, FLWs) who had been recommended for the role by the Community Leader, went door-to-door through the community to provide vouchers to caregivers with children under-5, aiming to reach all eligible households. 


Each caregiver was provided with a ‘voucher strip’ like the one below, perforated for ease of use. The Hausa text includes the brand “Garkuwar Iyali” (Family Shield), which we coined to represent the voucher program. The instructions inform caregivers that the vouchers must be used at least 4 weeks apart, the enforcement of which tested the system for spacing repeat claims over time as planned for reusable vouchers.


In addition to the vouchers, the FLWs gave caregivers a leaflet explaining ORSZ usage and triggers to seek further care, in Hausa language with pictograms for those who cannot read, plus a verbal explanation of the leaflet and the voucher system. FLWs registered each voucher strip by scanning the QR code with an Android phone and recording the number of under-5s looked-after by that caregiver.



Redeeming vouchers


PPMVs were trained on using an Android app to scan the QR codes on vouchers. The app, a custom configuration of CodeREADR, loaded the number of under-5s associated with each voucher code and uploaded voucher scans for monitoring when mobile connectivity was available. PPMVs were paid a participation incentive that included an allowance for mobile data costs and were asked to sync the app daily.


When a registered voucher was scanned, the app told the PPMV how many ORSZ co-packs to provide to the caregiver, based on the registration information that includes the number of children under-5 that the caregiver looks after. Unregistered or invalid voucher codes were rejected. The app also checked the date of any previous successful scan of the voucher code, and informed the PPMV how many days until the voucher could be used. (Recall that though we gave 2 single-use vouchers for pilot purposes, these had the same voucher code as we were also testing the capability to manage periodic repeat scans of the same re-usable voucher.)


In-person supervisory checks of the PPMVs work on the vouchers implementation (ie. visiting to check they were using the app correctly, managing stock appropriately, etc) were performed by the local primary healthcare focal person and Clear Solutions directly. This same person also provided additional cartons of ORSZ to the PPMVs when needed, from bulk stock provided by Clear Solutions.


Monitoring & Evaluation


During the pilot, we monitored the stream of voucher scans uploaded by the PPMVs via CodeREADR. A high proportion of the distributed voucher strips had a first ORSZ claim within a week of the service going live. This is expected: we consider the voucher model to be primarily “pre-emptive” provision of ORSZ (ie. for caregivers to keep at home until needed). However, we also expect that a certain proportion of caregivers would use the voucher ‘reactively’ by redeeming the voucher when a child has diarrhoea.


Operational metrics:

  • Voucher sets registered with caregivers: 1,898 sets of 2 vouchers

  • Under-5s at registered households: 3,450

  • Caregivers who successfully redeemed 1+ voucher: 1,601 (84% uptake)

  • Total ORSZ co-packs provided for under-5s: 4,207


The second voucher in each strip could be used 4+ weeks after the first. We decided not to issue any sort of reminder to caregivers (eg. no town crier or SMS) to observe the ‘unprompted’ return rate. Within the short 2-month pilot, approximately ⅓ of caregivers returned to use a second voucher. The ORSZ provision, 1 co-pack per under-5, was quite ‘generous’, in that the expected proportion of children suffering from diarrhoea each month is approximately 20%. Therefore many copacks will not have been used within the first 4 weeks (ie. still retained until needed), and in a longer-running program, this 4 week spacing would likely be increased to 2 or 3 months.


There were also many scans in the first few days where the voucher registration was not in CodeREADR. This is an area for improvement, which we understand to be a combination of the delay between frontline workers (FLWs) registering the voucher, the registration being uploaded by the FLW, then the registration being downloaded by the PPMV; and also imperfect registration implementation by the FLWs.


Analysis of the household survey data is ongoing, but provisionally, the impact on under-5 diarrhoea treatments with ORS and zinc seems very high, similar to the level we have seen previously in Kano for door-to-door campaigns.


* direct question ("Did you use ORS and/or zinc?")


It is premature to draw firm conclusions from ongoing analysis work, but we take this as a preliminary signal in favour of investing further in the Vouchers program, iterating upon its implementation, and exploring its long-term potential. We'll share more as we progress in the analysis and reflections.


We’d like to reiterate our thanks to our partners iDevPro Africa, Kano Ministry of Health, NAPPMED, and the individual PPMVs, FLWs and supervisor from Kabo LGA, Kano.

This October, we celebrated Clear Solutions’ second anniversary, marking two years since our founding in 2023. It has been a period defined by rapid iteration, ambitious scale-up, and a crucial evolution in how we deliver life-saving treatments to children most in need. We are profoundly grateful for the journey so far and thrilled by the opportunities that lie ahead.


In just two years, we have achieved significant reach. We are proud to announce that, to date, we have provided oral rehydration solution and zinc (ORSZ) co-packs to caregivers of an estimated 95,000 children under-5!


In our intervention regions in Nigeria and Chad, rates of child mortality from diarrhoea are tragically high, hundreds-of-times greater than in high-income countries. Driving the life-saving use of oral rehydration solutions and zinc (ORSZ), by improving access and knowledge, is crucial to giving children the chance to live their lives.



Learning from Dedicated Distributions: Pilot through Phase 3


Our first 16 months of programming focused intensely on dedicated, door-to-door distributions of ORSZ, primarily in Kano state, Nigeria, in partnership with locally-led organisation iDevPro Africa. This approach, heavily informed by a randomised controlled trial model from Uganda (Wagner et al, 2019), allowed us to rapidly refine our implementation and monitoring strategies.


Pilot (December 2023 – February 2024) The pilot phase in Kano reached approximately 6,900 children under-5. Surveys conducted post-distribution indicated a strong increase in the proportion of under-5 diarrhoea cases being treated with ORSZ. In the 4-week after distribution, surveys indicated a 42+ percentage points (pp) increase in diarrhoea cases treated with ORS and 61+ pp increase in combined ORS and zinc treatments compared to baseline. While we view these initial results with caution due to the simple pre-post evaluation methodology, they provided a solid directional signal in favour of iteration and scale-up. Read our pilot report here.


Phase 2: Scale-up and Closer Government Integration (Q2-3 2024) Phase 2 targeted reaching 20,000 children under-5, a nearly 3x scale-up from the pilot. Our focus shifted to testing operational scalability and enhancing evaluation rigour through a quasi-experimental methodology. A key milestone in this phase was the shift to a government supervision model, with leadership from the State Primary Healthcare system in training and supervising the community health worker distribution team. 


Phase 3: Digitisation and Precision Monitoring (Q4 2024 – Q1 2025) Phase 3 was critical for establishing the robust monitoring required for large-scale operations and reached an estimated 39000 children under-5. We fully embraced digitisation of distribution tracking, equipping CHWs with smartphones running GPS tracking tools. Given that communities often lack reliable household addressing systems, GPS recording provided crucial visibility into coverage, enabled highly effective supervision, and ensured accountability, which we consider a highly successful asset we take forward. Read more here.



Phase 4: The Layering Strategy and Geographic Expansion


As we concluded Phase 3, we reflected that the "last mile" effort in reaching every household with a single commodity was still a significant portion of the overall program cost, and was likely to remain that way even at large scale. To be as cost-effective, scalable, and sustainable as possible, we increased our focus on "layering" ORSZ provision onto carefully selected existing health delivery infrastructure, commencing in Q2 2025.


Phase 4 spans 3 different layering models:


1. Malaria Consortium SMC Layering in Chad: We expanded geographically to Chad in recognition of its extremely high diarrhoeal mortality rates and neglected status in ORSZ programming. We are partnering with Malaria Consortium to pilot integrated delivery of ORSZ co-packs alongside routine Seasonal Malaria Chemoprevention (SMC) door-to-door campaigns. This pilot, covering one health district to reach approximately 13,000 children under-5 is being rigorously evaluated in partnership with Dr Zachary Wagner of the University of Southern California to build a solid evidence base to inform future plans.


Read more about our Malaria Consortium partnership here and here.


2. Primary Healthcare Facilities in Nigeria: In Kogi state, we partnered with Notify Health to provide free ORSZ co-packs to caregivers of infants during routine immunisation clinics and community outreach sessions. In Kano, we are piloting the reactivation of ORS Corners at seven Primary Healthcare facilities in partnership with the Kano State Ministry of Health. These corners serve as key health education centres, providing free ORSZ and instruction to caregivers who seek facility-based care.


3. Community Medicine Vendors (PPMV Vouchers): Recognizing that many caregivers seek ORSZ treatment from local medicine vendors (“PPMVs”), we have implemented a voucher system to provide free ORSZ to caregivers of under-5s at these vendors in Kab LGA, Kano, with pilot distribution beginning November 2025.


Layering infrastructure reduces distribution costs and management load, offering a strong pathway to achieving impact at very large scale.



The Path Ahead: Phase 5 and Beyond


Our strategy moving forward is clear: to scale-up the best layering approaches. Planning for the subsequent phases of expansion in 2026 is underway, focused heavily on Phase 5 & 6.


Conditional on the ongoing evaluation results from Phase 4, Phase 5 will involve substantial scale-up, including (pending partner discussions) growing the Chad SMC collaboration considerably, scaling up the ORS Corners initiative in Nigeria, and expanding free ORSZ provision via the PPMV vendor voucher system. We aim to continue identifying and assessing further promising layering opportunities, maintaining our role as the agile innovator within the ORSZ ecosystem.


Acknowledgements

None of this progress would be possible without our trusted team, partners, and the dedicated individuals on the ground.


Our successes are fundamentally built upon the strength of our partnerships. We thank our Kano implementation partner, iDevPro Africa, who have been instrumental since the 2023 pilot. We are also deeply grateful to the State and Local Government Primary Healthcare systems in Nigeria for their collaboration, providing the integration necessary for scalability and sustainability. And for the collaboration on ORSZ layering onto SMC in Chad, we also warmly thank all the team at Malaria Consortium.


Crucially, we must acknowledge the sheer hard work of the Community Health Workers (CHWs) from the VCM and CHIPS Primary Healthcare programs, who have performed the door-to-door distributions. They, along with the data enumerators and survey staff who conducted rigorous monitoring and evaluation, are the frontline workers who put this program into action in challenging environments. They truly embody our mission to reach vulnerable households and ensure that no child dies a preventable death from diarrhoea.


We also recognise and thank our funding partners, including Effektiv Spenden, Founders Pledge, GiveWell, and Ultra Philanthropy who enable this important work to happen.



Thank you for following our journey! We look forward to sharing more progress as we continue to evolve and scale our life-saving programs in 2026 and beyond.

Clear Solutions’ first 16 months of programming focussed on dedicated distributions of oral rehydration solution and zinc (ORSZ) in Kano state, Nigeria. The distributors were community health workers engaged through partnerships with the State and Local Government Primary Healthcare system, facilitated by locally-led NGO partner iDevPro Africa.


These dedicated distributions enabled rapid iteration and adoption of advanced approaches for planning, monitoring and evaluation (eg. leveraging geographic information systems (GIS) mapping data and distributors’ GPS tracks). We also came to appreciate that the “last mile” effort in reaching each household with a single commodity was likely to remain significant as a proportion of overall program cost (with commodity procurement the other major part), even - or especially - with increased scale. We have thus increased focus on “layering” ORSZ provision onto existing healthcare infrastructure to achieve distribution cost efficiencies and leverage networks already operating at scale.


We are therefore thrilled to announce a collaboration with Malaria Consortium, to pilot

integrated delivery of ORSZ through their seasonal malaria chemoprevention (SMC) platform in Chad in the coming months.


Chad suffers a very high rate of child mortality from diarrhoeal diseases, 560 per 100,000 children under-5 in 2021 (per Global Burden of Disease, the West Sub-Saharan Africa regional average being 197). ORS remains highly under-utilised, with MICS 2019 finding all regions of Chad had <30% of under-5 diarrhoea cases treated with ORS, and some regions <10%.


SMC protects young children aged 3-59 months from malaria by administering antimalaria drugs in regular intervals or cycles during the high-transmission rainy season. The pilot will test community distribution of co-packaged ORSZ alongside routine SMC delivery across a whole health district, expecting to reach ~13,000 children under 5 years old.

SMC operations in Nigeria, 2023. Credit: Malaria Consortium
SMC operations in Nigeria, 2023. Credit: Malaria Consortium

ORSZ co-packs, one per child under 5, will be handed to caregivers during door-to-door SMC visits by trained community distributors, together with guidance on recognising diarrhoea symptoms, correct use of ORSZ, safe storage, and when to seek further care.


To maximise learning from the pilot, together we are taking a multi-pronged approach to monitoring and evaluation (M&E):

  1. Formative learnings to guide implementation details, eg. informal community discussions. The implementing team will give feedback on the operational impact of co-distribution.

  2. Malaria Consortium’s existing SMC distribution monitoring and coverage assessments will be extended to capture ORSZ data.

  3. Independent quasi-experimental evaluation of the intervention impact on ORS treatment rates will be monitored in the months following the distribution.


Through these M&E activities, we plan to build a solid evidence base to inform decisions on scale-up of this model in future years.


We thank the Malaria Consortium team for their partnership and are excited for the opportunities for large scale impact that this pilot may unlock!

Clear Solutions UK is a registered Charitable Incorporated Organisation in England and Wales (Charity Number 1214767).

In the USA, Clear Solutions is a project of Charity Entrepreneurship operating through a fiscal sponsorship with Players Philanthropy Fund, Inc. (Federal Tax ID: 27-6601178, ppf.org/pp), a Texas nonprofit corporation with federal tax-exempt status as a public charity under Section 501(c)(3) of the Internal Revenue Code.

Privacy Policy

Follow our work
  • X
  • LinkedIn

Subscribe to our newsletter to receive periodic updates.

Thanks for subscribing!

bottom of page